FDG PET in the differential diagnosis of parkinsonian disorders
Tóm tắt
Từ khóa
Tài liệu tham khảo
Antonini, 1998, Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET, Mov. Disord., 13, 268, 10.1002/mds.870130212
Barnes, 2000, The use of statistical parametric mapping (SPM96) as a decision aid in the differential diagnosis of dementia using 99mTc-HMPAO SPECT, Behav. Neurol., 12, 77, 10.1155/2000/482606
Blin, 1990, Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations, Arch. Neurol., 47, 747, 10.1001/archneur.1990.00530070035009
Blin, 1992, Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET, Mov. Disord., 7, 348, 10.1002/mds.870070409
Bonnet, 1987, Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?, Neurology, 37, 1539, 10.1212/WNL.37.9.1539
Chou, 2004, Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy, Case report, J. Neurosurg., 100, 553, 10.3171/jns.2004.100.3.0553
De Volder, 1989, Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration, Ann. Neurol., 26, 239, 10.1002/ana.410260210
Dhawan, 2003, PET imaging in Parkinson's disease, 251
Dhawan, 1998, Quantitative Brain PET. Comparison of 2D and 3D Acquisitions on the GE Advance Scanner, Clin. Positron Imaging, 1, 135, 10.1016/S1095-0397(98)00009-0
Diamond, 1987, Multi-center study of Parkinson mortality with early versus later dopa treatment, Ann. Neurol., 22, 8, 10.1002/ana.410220105
Eckert, 2004, The role of functional neuroimaging in the differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy, Clin. Auton. Res., 14, 84, 10.1007/s10286-004-0167-1
Eckert, 2004, Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging, NeuroImage, 21, 229, 10.1016/j.neuroimage.2003.08.028
Eidelberg, 1991, The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography, J. Neurol., Neurosurg. Psychiatry, 54, 856, 10.1136/jnnp.54.10.856
Eidelberg, 1993, Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease, Ann. Neurol., 33, 518, 10.1002/ana.410330517
Eidelberg, 1994, The metabolic topography of parkinsonism, J. Cereb. Blood Flow. Metab., 14, 783, 10.1038/jcbfm.1994.99
Fahn, 2004, Levodopa and the progression of Parkinson's disease, N. Engl. J. Med., 351, 2498, 10.1056/NEJMoa033447
Fearnley, 1991, Ageing and Parkinson's disease: substantia nigra regional selectivity, Brain, 114, 2283, 10.1093/brain/114.5.2283
Feigin, 2002, Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism, Mov. Disord., 17, 1265, 10.1002/mds.10270
Foster, 1988, Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography, Ann. Neurol., 24, 399, 10.1002/ana.410240308
Friston, 1995, Statistical parametric maps in functional imaging: a general linear approach, Hum. Brain Mapp., 2, 189, 10.1002/hbm.460020402
Friston, 1996, Detecting activations in PET and fMRI: levels of inference and power, NeuroImage, 4, 223, 10.1006/nimg.1996.0074
Golbe, 1988, Prevalence and natural history of progressive supranuclear palsy, Neurology, 38, 1031, 10.1212/WNL.38.7.1031
Hughes, 1992, The dopaminergic response in multiple system atrophy, J. Neurol., Neurosurg. Psychiatry, 55, 1009, 10.1136/jnnp.55.11.1009
Hughes, 1992, Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases, J. Neurol., Neurosurg. Psychiatry, 55, 181, 10.1136/jnnp.55.3.181
Hughes, 2002, The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service, Brain, 125, 861, 10.1093/brain/awf080
Krack, 2000, Thalamic, pallidal, or subthalamic surgery for Parkinson's disease?, J. Neurol., 247, 122, 10.1007/PL00022913
Laureys, 1999, Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration, J. Neurol., 246, 1151, 10.1007/s004150050534
Lee, 1994, Clinical observations on the rate of progression of idiopathic parkinsonism, Brain, 117, 501, 10.1093/brain/117.3.501
Lezcano, 2004, Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report, Mov. Disord., 19, 973, 10.1002/mds.20108
Lijmer, 1999, Empirical evidence of design-related bias in studies of diagnostic tests, JAMA, 282, 1061, 10.1001/jama.282.11.1061
Litvan, 1999, Recent advances in atypical parkinsonian disorders, Curr. Opin. Neurol., 12, 441, 10.1097/00019052-199908000-00011
Litvan, 1998, Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy, J. Neural Transm., 105, 217, 10.1007/s007020050050
Martin, 2003, Treatment of Parkinson's disease, Can. J. Neurol. Sci., 30, S27, 10.1017/S0317167100003218
Moeller, 1999, Reproducibility of regional metabolic covariance patterns: comparison of four populations, J. Nucl. Med., 40, 1264
Moghal, 1994, Prevalence of movement disorders in elderly community residents, Neuroepidemiology, 13, 175, 10.1159/000110376
Olanow, 2002, Surgical therapy for Parkinson's disease, Eur. J. Neurol., 9, 31, 10.1046/j.1468-1331.9.s3.4.x
Osaki, 2002, Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?, Neurology, 59, 1486, 10.1212/01.WNL.0000028690.15001.00
Otsuka, 1996, Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study, J. Neurol. Sci., 144, 77, 10.1016/S0022-510X(96)00172-4
Parati, 1993, Response to l-DOPA in multiple system atrophy, Clin. Neuropharmacol., 16, 139, 10.1097/00002826-199304000-00006
2002, Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression, JAMA, 287, 1653, 10.1001/jama.287.13.1653
Piccini, 2001, Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18Fluorodeoxyglucose positron emission tomography, Arch. Neurol., 58, 1846, 10.1001/archneur.58.11.1846
Poline, 1995, Estimating smoothness in statistical parametric maps: variability of P values, J. Comput. Assist. Tomogr., 19, 788, 10.1097/00004728-199509000-00017
Signorini, 1999, Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping, NeuroImage, 9, 63, 10.1006/nimg.1998.0381
Taniwaki, 2002, Cerebral metabolic changes in early multiple system atrophy: a PET study, J. Neurol. Sci., 200, 79, 10.1016/S0022-510X(02)00151-X
Tarsy, 2003, Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy, Neurology, 61, 247, 10.1212/01.WNL.0000073986.74883.36
Tintner, 2002, Treatment options for Parkinson's disease, Curr. Opin. Neurol., 15, 467, 10.1097/00019052-200208000-00011
Van Laere, 2004, Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters, J. Nucl. Med., 45, 933
Visser-Vandewalle, 2003, Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy-parkinsonism. Report of four cases, J. Neurosurg., 98, 882, 10.3171/jns.2003.98.4.0882
Wenning, 1997, Multiple system atrophy: a review of 203 pathologically proven cases, Mov. Disord., 12, 133, 10.1002/mds.870120203